Thomas Daniel

Thomas Daniel

Director/Board Member at GOSSAMER BIO, INC.

Net worth: 8 800 $ as of 2026-05-30

72 year
Health Technology
Consumer Services
Commercial Services

Profile

Thomas O.
Daniel
is currently Chairman-Overseers Board at The Scripps Research Institute; Chairman at Locanabio, Inc. since 2017; Chairman at Life Science Cares San Diego LLC; Chairman at Gate Therapeutics; Chairman at Trotana, Inc.; Director at FerruMax Pharmaceuticals, Inc.; Director at Lupus Research Alliance, Inc.; Independent Director at Gossamer Bio, Inc. since 2018; Director at Aspen Neuroscience, Inc. since 2020; Director at Mozart Therapeutics, Inc. since 2020; and Trustee at The Reed Institute since 2017.
Former roles include Chairman-Research Division at Celgene Corp.
in 2016; Independent Director at Zafgen, Inc. from 2016 to 2020; Director at Abide Therapeutics, Inc.; Director at PharmAkea, Inc.; Chief Scientific Officer & Director at Ambrx, Inc.; Director at Alliance for Lupus Research; Director at Pharmaceutical Research & Manufacturers of America; Director at Epizyme, Inc. from 2012 to 2014; Director at Epizyme, Inc.; Director at ImmusanT, Inc. from 2017 to 2019; Independent Director at Juno Therapeutics, Inc. from 2015 to 2018; Executive Director at Catalyst Advisors LP; Independent Director at Magenta Therapeutics, Inc.; Independent Director at Vir Biotechnology, Inc.; Director at Vanderbilt Vascular Biology Center; Director at Sana Biotechnology, Inc.; Independent Director at Larimar Therapeutics, Inc. from 2020 to 2022; Director at Vividion Therapeutics, Inc.; Vice President-Research at Amgen, Inc. from 2002 to 2003; Senior Vice President-Discovery Research at Immunex Corp.
from 2000 to 2002; Venture Partner at ARCH Venture Partners LLC from 2016 to 2021; and Professor at Vanderbilt University.
Education includes an undergraduate degree from Southern Methodist University in 1974; a doctorate from The University of Texas at Austin in 1978; and a doctorate from The University of Texas Southwestern Medical Center in 1978.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-03 38,095 ( 0.01% ) 8 800 $ 2026-05-30

Thomas Daniel active positions

CompaniesPositionStart
GOSSAMER BIO, INC. Director/Board Member 2017-12-31
Director/Board Member -
Director/Board Member 2020-01-31
Director/Board Member 2020-05-31
Chairman -
Director/Board Member 2017-02-28
Chairman -
Corporate Officer/Principal -
Director/Board Member -

Former positions of Thomas Daniel

CompaniesPositionEnd
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Thomas Daniel's experience

Training of Thomas Daniel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

34

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies34

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Services

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services